D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced /?rb??s?rt?n/) is an angiotensin avapro for blood pressure receptor antagonist used mainly for the treatment of hypertension. Irbesartan may also delay progression of avapro for blood pressure nephropathy and is also indicated for the treatment of hypertension.

II receptor antagonist used mainly for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also avapro for blood pressure for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). avapro for blood pressure is jointly marketed by sanofi-aventis and Bristol-Myers Squibb under the trade names to avapro for blood pressure preparations, including CoAprovel, Karvezide, Avalide and Avapro HCT.[edit] References^ Lewis EJ, Hunsicker LG, Clarke avapro for blood pressure Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study avapro for blood pressure (2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes,[1] hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).[2][edit] Combination with diureticIrbesartan is also available avapro for blood pressure a combination formulation with a avapro for blood pressure dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive.

the free encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC).